UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000028517
Receipt number R000027726
Scientific Title A feasibility study of EdoXaban for the Cancer-Associated asymptomatic Venous thromboEmbolism in Japanese gastrointestinal cancer patients receiving chemotherapy. (ExCAVE study)
Date of disclosure of the study information 2017/08/22
Last modified on 2021/11/15 14:15:54

No. Disposal Last modified on Item of update
1 Insert 2017/08/03 14:53:18
2 Update 2017/08/03 14:54:23 Public title
3 Update 2017/08/04 14:40:40 Narrative objectives1
Narrative objectives1
Basic objectives2
Primary outcomes
Key secondary outcomes
4 Update 2017/08/04 14:48:09 Key secondary outcomes
Key secondary outcomes
5 Update 2017/08/04 15:32:40 Key secondary outcomes
6 Update 2017/08/04 15:35:46 Key secondary outcomes
Key secondary outcomes
7 Update 2017/08/04 15:41:20 Primary outcomes
Key secondary outcomes
8 Update 2017/08/04 15:49:02 Interventions/Control_1
Interventions/Control_1
9 Update 2017/08/04 15:54:48 Key inclusion criteria
10 Update 2017/08/04 16:00:29 Key inclusion criteria
11 Update 2017/08/04 16:10:08 Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
12 Update 2017/08/22 12:57:48 Date of disclosure of the study information
13 Update 2018/02/17 12:48:48 Recruitment status
14 Update 2018/10/29 18:33:13 Key exclusion criteria
Key exclusion criteria
15 Update 2021/11/15 13:06:36 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Division name
Division name
Zip code
Address
Address
TEL
Email

Last name of contact person

Last name of contact person
Zip code
Name of person sending information
Name of person sending information
Organization
Organization1
Address1
Tel1
Email1
Organization
Organization
Address
Address
Tel
Email
Secondary IDs
Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
16 Update 2021/11/15 14:15:54 Recruitment status
Date of IRB
Last follow-up date